Title: Precancers and Skin Cancers
1Precancers and Skin Cancers
- Adam O. Goldstein, MD, MPH
- Associate Professor
- Family Medicine
- University of North Carolina at Chapel Hill
- aog_at_med.unc.edu
2Actinic Keratoses
- premalignant skin lesions keratinocytic
intraepidermal neoplasia - chronic sun, radiation or polycyclic aromatic
hydrocarbons - Skin Type I-II
- organ transplant
3Actinic Keratosis
4Actinic Keratoses
- Distribution Sunexposed, esp. dorsa
hands/forearms - Description papules,plaques with scale and
erythema, occasional crust or cutaneous horn - Sandpapery feel
5Actinic Keratoses
- epidermal atypia
- abnormal maturation
6Actinic Keratoses
- 60 predisposed gt40 have at least 1 AK
- 6-10 lifetime gtgt invasive SCC
- gt10 AK - 14 an SCC w/n 5 yrs
- 60-97 of SCC from AK
- 40 of met SCCgtgt AK
- aggressive immsupp
7Actinic Keratoses
- lip lesions actinic cheilitis/leukoplakia
- white plaques-mucosa
- persistent scaling lesions on the lip
- aggressive behavior
- tobacco/sun
8Differential Diagnosis
- squamous cell carcinoma more indurated, thicker,
recurrence of AK after treatment
9Differential Diagnosis
- seborrheic keratosis hyperpigmented,more stuck
on appearing
10Differential Diagnosis
- nummular eczema coin-shaped scaling lesions
responds to emollients/topical corticosteroids
11AK Treatment
- PREVENTION
- Screen for skin cancers
- Broad-brimmed hats
- sun protective clothing
- sunscreens
- avoidance of sunlight
- ed s/sx skin cancer
- avoidance of tobacco
- low fat diet?
12AK Treatment
- Cryosurgery(liquid nitrogen)
- 5-fluorouracil cream or solution
- Diclofenac Sodium-3 gel
- Imiquimod 2 x week/ 16 weeks
13AK Treatment
- Excision
- Electrocautery
- Curettage
- Carbon dioxide laser
14AK Treatment
- Chemical peels
- Photodynamic therapy
- Retinoids-topical/oral
- Investigational-dimericine
15TREATMENT
- Liquid Nitrogen-Advantages
- cure rates of 98.8
- common
- minimal patient ed
- multiple/thicker lesions
- quick recovery
16TREATMENT
- Liquid Nitrogen-Disadvantages
- storage
- pain
- pigment alteration
- training
175-Fluorouracil
- Cure 50-80
- Blocks methylation reaction of deoxyuridylic acid
to thymidilic acid - DNA (and RNA) synthesis
18Diclonfenac Sodium 3 Topical Gel
- mechanism of action unknown
- NSAID
- inhibition of cyclo-oxygenase gtgtgtPGE-2
- 90 days BID--overall 33-47 clearance vs 10-19
vehicle - avoid ASA triad
- hypersensitivity
19Photodynamic therapy
(Pariser DM - J Am Acad Dermatol -2003)
20 Cycle therapy of actinic keratoses of the face
and scalp with 5 topical imiquimod cream An
open-label trial.
Significant irritation Rest periods
required Evolving protocols Expensive Effective
Salasche SJ et al Am Acad Dermatol 200247571-7.
21Skin Cancer Statistics
- gt1 million cases/yr
- gt50 of all new cancers
- 1 in 5 Americans will develop skin cancer
22Types of Skin Cancers
- Basal Cell Carcinoma - 80
- Squamous Cell Carcinoma - 16
- Melanoma - 4
23BCC /SCC
- Most common skin cancers
- Most important risk factors
- sun exposure
- family history
- skin type
- Incidence of these cancers increase with age,
probably related to cumulative sun exposure
24Basal Cell Carcinoma
- the most common skin cancer
- 90 appear on face, ears, head
25Main Types Basal Cell Carcinomas
- Nodular BCCs - most common type
- Sclerosing BCCs (morpheaform)
- Superficial BCCs
26Pattern of Nodular BCC
- raised pearly white, smooth translucent surface
with telangiectasias
27Pattern of Nodular BCCs
- may ulcerate leaving a small bloody crust
- may be pigmented
28Pattern of Sclerosing BCCs
- ivory or colorless
- flat or atrophic
- indurated
- may resemble scars
- are easily overlooked
29Pattern of Sclerosing BCCs
- ivory or colorless
- flat or atrophic
- indurated
- may resemble scars
- are easily overlooked
30Pattern of Superficial BCCs and SCC in situ
- red or pink scaling plaques
- occasionally with shallow erosions or crusts
- differentiation between these two similar lesions
usually requires a biopsy
31Pigmented BCCs
- may look like melanoma
- increased brown or black pigment
- seen more commonly in dark-skinned individuals
32Differential Diagnosis of Nodular BCC
- Intradermal nevus
- Sebaceous hyperplasia
- Fibrous papule of the face
- trichoepithelioma
33Differentiating Intradermal Nevus from Nodular BCC
- Intradermal nevus
- Stable size
- Soft
- No crusting or ulceration
- May have telangiectasias
34Differentiating Intradermal Nevus from Nodular BCC
- Intradermal nevus
- Stable size
- Soft
- No crusting or ulceration
- May have telangiectasias
35Sebaceous Hyperplasia from Nodular BCC
- Sebaceous hyperplasia
- yellow coloration
- stable size
- umbilication without ulceration
- is hard to see after injecting anesthesia
36Diagnosis of Basal Cell Carcinomas
- Shave biopsy
- nodular
- thick superficial types
- Punch biopsy
- morpheaform
- flat superficial types
37Treatment options for Basal Cell Carcinomas
- C D after a shave biopsy
- Cryotherapy with thermocouple if you have
experience - Excision with 3- 5 mm margins
- Superficial trunk/ext imiquimod qd x 12 wks
- Mohs for recurrent BCC and areas of cosmetic
importance
38Mohs micrographic surgery
- removal of tumor by scalpel in sequential
horizontal layers. - each tissue sample is frozen, stained, and
microscopically examined - repeated until all the margins are clear
- treatment of choice for BCCs with poorly defined
margins - especially those on the nose or eyelids
39Recurrence rates after Tx of BCCs
- C D 10
- Cryotherapy 10
- Excision 2 - 5
- Imiquimod ???
- Mohs lt1
40Factors that increase recurrence rates
- sclerosing vs others
- larger size of BCC
- margins
- experience of the surgeon
41Sclerosing BCC is most dangerous
- tend to be deeply invasive
- often not diagnosed until they have caused
extensive damage - invade muscle, nerve, and bone
- nodular BCC can also invade deeply
42Bowens disease - features
- SCC in situ
- Mainly sun exposed areas
- Slightly elevated red scaly plaque with
well-demarcated borders
43Bowens disease - features
- May resemble psoriasis, superficial BCC, chronic
eczema, SK - Curable using C D, cryo, 5-FU, imiquimod,
excision
44Keratoacanthoma
- Appear suddenly, grow rapidly
- Central crater with keratin plug
- May grow to 2cm in size
- May resolve spontaneously
- May look like SCC
45Keratoacanthoma
- C and D
- elliptical excision
- 5-FU topically tid
- 5-FU intralesional injection
46Location of SCCs
- Same distribution as bccs.
- Especially on the lips, ears, and scalp
- Initially grow by direct extension
- Metastasize to local lymph nodes and then to
distant sites
47SCCs with an increased risk of metastasis
- larger, advanced lesions
- SCC on mucous membranes (in the oral cavity, on
the lips) - BCCs rarely metastasize
48SCC more aggressive (local mets)
- Size gt2 cm
- SCC in a scar
- Patient is immunosuppressed
- Poorly differentiated
- There is perineural invasion
49Importance of early diagnosis of BCC and SCC
- especially in facial cancers
- the nose is the single most frequent site of BCC
- reconstruction is difficult
- extension into underlying bone and cartilage may
occur
50The differential diagnosis of superficial BCC and
SCC in situ
- Actinic keratosis, nummular eczema
- Nummular eczema can usually be distinguished by
its coin-like shape, transient nature, and
itchiness - Biopsy any thickened and crusting actinic
keratosis to rule out BCC or SCC
51Treatment options for SCC
- C D after a shave biopsy
- cryotherapy with thermocouple if you have
experience - excision with 5 mm margin
- Mohs for recurrent SCC and areas of cosmetic
importance
52Erythroplasia of Queyrat
- SCC in situ on the penis
- Usually under the foreskin of the uncircumcised
penis - May occur on the vulva
- 5-FU, imiquimod or mohs
53Indications for Referral for Mohs Surgery
54Indications for Referral for Mohs Surgery
- Recurrent tumors, sclerosing BCC
- Primary tumors in locations with high
tumor-recurrence rates - Nasolabial fold,temple, periauricular area,
periocular area, scalp, nasal alae, center face - Preservation of normal tissue is vital (for
cosmetic and functional reasons) - Nose, eyelids, lips, fingers, ears, penis
55When to consider referral
- Aggressive and recurrent skin cancers
- A large skin cancer lesion
- A lesion located in a sensitive area (cosmetic or
functional) - When treatment or diagnosis of the lesion is
beyond the scope of ones skills - If mohs surgery is the treatment of choice
56Melanoma Risk Factors
- Family history
- Personal history
- Atypical Nevi
- Blistering Sunburns
- Type 1 skin
57History of a changing lesion
58Melanoma Statistics
- Fastest rising incidence rates
- Most common cancer in 25-9 y/o
- 2nd only to breast CA in 30-4 y/o women
59Melanoma Facts
- 87,900 new cancers
- 34,300 in situ
- 53,600 invasive
- 4 increase from 2001
- 7400 deaths in 2003 due to melanoma
60Melanoma
61Melanoma-Early detection
- Total treatment costs by stage
- Stage I 5.5
- Stage II 5.5
- Stage III 34
- Stage IV 55
62MNEMONIC FOR MALIGNANT MELANOMA RECOGNITION
- A- ASYMMETRY
- B- BORDER IRREGULARITY
- C- VARIATION IN COLOR
- D- DIAMETERgt .6CM
- E- ELEVATION ABOVE SKIN SURFACE
63Melanoma with regression
64Melanoma
65Acral lentiginous Melanoma
66Lentigo Maligna Melanoma
67Venous Lake
68Blue Nevus
69Seborrheic Keratosis
70Pyogenic Granuloma
71Look everywhere
72Melanoma Management
- Excisional biopsy
- 1-2 mm margins
- Dermatopathologist consultation
73Breslows Measurement
- Depth of granular cell layer to deepest malignant
cell - Strongest correlation with prognosis
74Melanoma Managment
- Sentinel lymph node biopsy
- 1mm or greater depth, regression, gtLevel III or
IV - Interferon
- Vaccine clinical trials
75Melanoma Management
- Full skin exam
- Family screening
- Follow up
- Education
76Take home points
- Prevent skin cancers by risk factor reduction
- Early detection of pre-cancers and skin cancers
can prevent morbidity and mortality - Use the appropriate biopsy technique for
diagnosing skin cancers - Treat or refer based on your skills
77Online References
- Derm Online Atlas is at www.dermis.net/bilddb/inde
x_e.htm - Derm Image Bank is at medstat.med.utah.edu/kw/derm
/ - Basal Cell Carcinoma is at emedicine.com/derm/topi
c47.htm